# LENZ Therapeutics, Inc.: Form 8-K, filed Mar 24, 2026

- Company: [LENZ Therapeutics, Inc.](/companies/lenz.md) (CIK 1815776)
- Form: 8-K
- Filed: 2026-03-24
- Accepted by EDGAR: Mar 24, 2026, 08:10 ET
- Period: 2026-03-24
- Accession: 0001815776-26-000008
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1815776/000181577626000008/lenz-20260324.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1815776/000181577626000008/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1815776/000181577626000008/lenz-20260324.htm

Filed Mar 24, 2026.
Source: SEC EDGAR, the filing index for accession 0001815776-26-000008. Last ingested by Listed: Nov 5, 2026, 13:56 ET. No prices; not investment advice.
